M. Kulyk & Associates’s Albemarle ALB Stock Holding History

M. Kulyk & Associates’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,122	Closed	-$201K	–	115
2026 Q1	$201K	Buy	+1,122	New	+$192K	0.04%	118

Other funds holding ALB

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

M. Kulyk & Associates's ALB Position: Q2 2026 in Review

M. Kulyk & Associates sold out of Albemarle (ALB) in Q2 2026, closing a stake of 1,122 shares — an estimated $201K sold.

M. Kulyk & Associates first reported a position in ALB in Q1 2026 and held it in 1 quarter. The position peaked at $201K in Q1 2026. 942 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

M. Kulyk & Associates reported no remaining Albemarle position as of Q2 2026 after selling out during the quarter.
M. Kulyk & Associates sold 1,122 Albemarle shares in Q2 2026, an estimated $201K.
M. Kulyk & Associates first reported a position in Albemarle in Q1 2026 and held it in 1 quarter.
M. Kulyk & Associates's Albemarle position peaked at $201K in Q1 2026.
942 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on M. Kulyk & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.